Company intelligence / Profile preview

Miramar Labs

Santa Clara, California, United Statessec.gov ↗

Ownership: Private
Employees: ~41
Development stage: Commercial

Overview

Miramar Labs developed the miraDry system using its proprietary miraWave microwave energy platform. The system provides a non-invasive, FDA-cleared treatment for permanent reduction of underarm sweat, odor, and hair of all colors. Clinical studies demonstrated an average 82% reduction in sweat with immediate and long-lasting results after a single treatment. The technology has been commercialized globally and was supported by rigorous clinical research[5][6][7][9].

Therapeutic areas: Dermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

miraDry System

Commercial

Indications: Hyperhidrosis, Axillary hair removal, Axillary odor

Partnerships

No major disclosed pharma/biotech partnerships prior to acquisition.

Beyond the preview

Go deeper on Miramar Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Miramar Labs.

Explore the full profile